Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1309480

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1309480

LAMEA Helicobacter Pylori Diagnostics Market Size, Share & Industry Trends Analysis Report By Test Type (Non-invasive and Invasive), By End User, By Method (Laboratory Based Test and Point of Care Test), By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Helicobacter Pylori Diagnostics Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030).

Helicobacter pylori (H. pylori) is a bacteria that can stay in the digestive tract after they enter the body. These bacteria can eventually lead to ulcers, which are sores that develop on the stomach or upper small intestinal lining. Hence, the need for diagnosis is increasing to decrease the cases of patients with ulcers or gastric cancer. The key factors propelling the market growth are the development in diagnostics methods, growing infectious diseases, and the rising cases of gastric cancer, which are projected to drive market growth.

Due to the availability of many cutting-edge technologies, including enzyme immunoassays, which are utilized for the detection of antibodies, the immunoassay segment, which currently accounts for a sizeable portion of the market, is predicted to exhibit a similar pattern over the projected period. The main drivers in the immunoassay are the increased incidence of gastritis and Helicobacter pylori infections and technical developments.

In Brazil, So Paulo (25.0), Goiania (23.7), and Curitiba (21.6) had the greatest annual average incidence rates for gastric cancer, adjusted by age per 100 thousand men, for the PBCRs that were analyzed. In terms of women, Goiania (11.3), So Paulo (11.01), and Ja (9.0) had the highest age-adjusted annual average incidence rates per one hundred thousand women. Recife (11.8 for males) and Joo Pessoa (5.2 for women) were the cities with the lowest rates. According to the 2013 Saudi Arabia Cancer Incidence Report, the incidence rate for newly diagnosed cases of gastric cancer in Saudi Arabia was 2.7% in 2013. As a result, the LAMEA market is anticipated to expand due to the growing gastric cancer cases, which is expected to increase the demand for diagnostics to identify helicobacter pylori will drive the market growth.

The Brazil market dominated the LAMEA Helicobacter Pylori Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $13.1 Million by 2030. The Argentina market is estimated to grow a CAGR of 8.2% during (2023 - 2030). Additionally, The UAE market would experience a CAGR of 7.3% during (2023 - 2030).

Based on Test Type, the market is segmented into Non-invasive and Invasive. Based on End User, the market is segmented into Diagnostics Laboratories, Hospitals, and Others. Based on Method, the market is segmented into Laboratory Based Test and Point of Care Test. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Biohit Oyj, Abbott Laboratories, Quidel Corporation, Gulf Coast Scientific, Inc. (Gulf Coast Medical Center), Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.), Avanos Medical, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd.

Scope of the Study

Market Segments covered in the Report:

By Test Type

  • Non-invasive
  • Invasive

By End User

  • Diagnostics Laboratories
  • Hospitals
  • Others

By Method

  • Laboratory Based Test
  • Point of Care Test

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Cardinal Health, Inc.
  • Biohit Oyj
  • Abbott Laboratories
  • Quidel Corporation
  • Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
  • Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
  • Avanos Medical, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Helicobacter Pylori Diagnostics Market, by Test Type
    • 1.4.2 LAMEA Helicobacter Pylori Diagnostics Market, by End User
    • 1.4.3 LAMEA Helicobacter Pylori Diagnostics Market, by Method
    • 1.4.4 LAMEA Helicobacter Pylori Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Helicobacter Pylori Diagnostics Market by Test Type

  • 3.1 LAMEA Non-invasive Market by Country
  • 3.2 LAMEA Invasive Market by Country

Chapter 4. LAMEA Helicobacter Pylori Diagnostics Market by End User

  • 4.1 LAMEA Diagnostics Laboratories Market by Country
  • 4.2 LAMEA Hospitals Market by Country
  • 4.3 LAMEA Others Market by Country

Chapter 5. LAMEA Helicobacter Pylori Diagnostics Market by Method

  • 5.1 LAMEA Laboratory Based Test Market by Country
  • 5.2 LAMEA Point of Care Test Market by Country

Chapter 6. LAMEA Helicobacter Pylori Diagnostics Market by Country

  • 6.1 Brazil Helicobacter Pylori Diagnostics Market
    • 6.1.1 Brazil Helicobacter Pylori Diagnostics Market by Test Type
    • 6.1.2 Brazil Helicobacter Pylori Diagnostics Market by End User
    • 6.1.3 Brazil Helicobacter Pylori Diagnostics Market by Method
  • 6.2 Argentina Helicobacter Pylori Diagnostics Market
    • 6.2.1 Argentina Helicobacter Pylori Diagnostics Market by Test Type
    • 6.2.2 Argentina Helicobacter Pylori Diagnostics Market by End User
    • 6.2.3 Argentina Helicobacter Pylori Diagnostics Market by Method
  • 6.3 UAE Helicobacter Pylori Diagnostics Market
    • 6.3.1 UAE Helicobacter Pylori Diagnostics Market by Test Type
    • 6.3.2 UAE Helicobacter Pylori Diagnostics Market by End User
    • 6.3.3 UAE Helicobacter Pylori Diagnostics Market by Method
  • 6.4 Saudi Arabia Helicobacter Pylori Diagnostics Market
    • 6.4.1 Saudi Arabia Helicobacter Pylori Diagnostics Market by Test Type
    • 6.4.2 Saudi Arabia Helicobacter Pylori Diagnostics Market by End User
    • 6.4.3 Saudi Arabia Helicobacter Pylori Diagnostics Market by Method
  • 6.5 South Africa Helicobacter Pylori Diagnostics Market
    • 6.5.1 South Africa Helicobacter Pylori Diagnostics Market by Test Type
    • 6.5.2 South Africa Helicobacter Pylori Diagnostics Market by End User
    • 6.5.3 South Africa Helicobacter Pylori Diagnostics Market by Method
  • 6.6 Nigeria Helicobacter Pylori Diagnostics Market
    • 6.6.1 Nigeria Helicobacter Pylori Diagnostics Market by Test Type
    • 6.6.2 Nigeria Helicobacter Pylori Diagnostics Market by End User
    • 6.6.3 Nigeria Helicobacter Pylori Diagnostics Market by Method
  • 6.7 Rest of LAMEA Helicobacter Pylori Diagnostics Market
    • 6.7.1 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Test Type
    • 6.7.2 Rest of LAMEA Helicobacter Pylori Diagnostics Market by End User
    • 6.7.3 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Method

Chapter 7. Company Profiles

  • 7.1 Biohit Oyj
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional Analysis
    • 7.1.4 Research & Development Expenses
  • 7.2 Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
    • 7.2.1 Company Overview
  • 7.3 Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Recent strategies and developments:
      • 7.3.3.1 Acquisition and Mergers:
  • 7.4 Avanos Medical, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expenses
  • 7.5 Abbott Laboratories
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 SWOT Analysis
  • 7.6 Thermo Fisher Scientific, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 SWOT Analysis
  • 7.7 F. Hoffmann-La Roche Ltd.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Quidel Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Cardinal Health, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
  • 7.10. Bio-Rad laboratories, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 LAMEA Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Non-invasive Market by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Non-invasive Market by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Invasive Market by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Invasive Market by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Diagnostics Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Diagnostics Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Laboratory Based Test Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Laboratory Based Test Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Point of Care Test Market by Country, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Point of Care Test Market by Country, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Helicobacter Pylori Diagnostics Market by Country, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Helicobacter Pylori Diagnostics Market by Country, 2023 - 2030, USD Million
  • TABLE 25 Brazil Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 26 Brazil Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 27 Brazil Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 28 Brazil Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 29 Brazil Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 30 Brazil Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 31 Brazil Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 32 Brazil Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 33 Argentina Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 34 Argentina Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 35 Argentina Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 36 Argentina Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 37 Argentina Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 38 Argentina Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 39 Argentina Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 40 Argentina Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 41 UAE Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 42 UAE Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 43 UAE Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 44 UAE Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 45 UAE Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 46 UAE Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 47 UAE Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 48 UAE Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 49 Saudi Arabia Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 50 Saudi Arabia Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 51 Saudi Arabia Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 52 Saudi Arabia Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 53 Saudi Arabia Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 54 Saudi Arabia Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 55 Saudi Arabia Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 56 Saudi Arabia Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 57 South Africa Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 58 South Africa Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 59 South Africa Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 60 South Africa Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 61 South Africa Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 62 South Africa Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 63 South Africa Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 64 South Africa Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 65 Nigeria Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 66 Nigeria Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 67 Nigeria Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 68 Nigeria Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 69 Nigeria Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 70 Nigeria Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 71 Nigeria Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 72 Nigeria Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 73 Rest of LAMEA Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
  • TABLE 74 Rest of LAMEA Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
  • TABLE 75 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
  • TABLE 76 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
  • TABLE 77 Rest of LAMEA Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
  • TABLE 78 Rest of LAMEA Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
  • TABLE 79 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
  • TABLE 80 Rest of LAMEA Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
  • TABLE 81 Key Information - Biohit Oyj
  • TABLE 82 Key Information - Gulf Coast Scientific, Inc.
  • TABLE 83 Key Information - Meridian Bioscience, Inc.
  • TABLE 84 Key Information - Avanos Medical, Inc.
  • TABLE 85 Key Information - Abbott Laboratories
  • TABLE 86 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 87 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 88 key information - Quidel Corporation
  • TABLE 89 key information - Cardinal Health, Inc.
  • TABLE 90 Key Information - Bio-Rad Laboratories, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 LAMEA Helicobacter Pylori Diagnostics Market share by Test Type, 2022
  • FIG 3 LAMEA Helicobacter Pylori Diagnostics Market share by Test Type, 2030
  • FIG 4 LAMEA Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2030, USD Million
  • FIG 5 LAMEA Helicobacter Pylori Diagnostics Market share by End User, 2022
  • FIG 6 LAMEA Helicobacter Pylori Diagnostics Market share by End User, 2030
  • FIG 7 LAMEA Helicobacter Pylori Diagnostics Market by End User, 2019 - 2030, USD Million
  • FIG 8 LAMEA Helicobacter Pylori Diagnostics Market share by Method, 2022
  • FIG 9 LAMEA Helicobacter Pylori Diagnostics Market share by Method, 2030
  • FIG 10 LAMEA Helicobacter Pylori Diagnostics Market by Method, 2019 - 2030, USD Million
  • FIG 11 LAMEA Helicobacter Pylori Diagnostics Market share by Country, 2022
  • FIG 12 LAMEA Helicobacter Pylori Diagnostics Market share by Country, 2030
  • FIG 13 LAMEA Helicobacter Pylori Diagnostics Market by Country, 2019 - 2030, USD Million
  • FIG 14 Swot analysis: Abbott laboratories
  • FIG 15 Swot analysis: thermo fisher scientific, inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!